Variant report
Variant | nsv575478 |
---|---|
Chromosome Location | chr17:46400653-46402212 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:46402150..46403911-chr17:46405862..46407499,2 | K562 | blood: | |
2 | chr17:46401524..46403183-chr17:46407797..46409461,2 | K562 | blood: | |
3 | chr17:46399623..46402614-chr17:46666348..46668783,2 | K562 | blood: | |
4 | chr17:46393909..46396723-chr17:46401139..46403154,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000233101 | chromatin interactions |
ENSG00000120093 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4451990 | chr17:46400653-46400654 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs530808087 | chr17:46400715-46400716 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs550947870 | chr17:46400733-46400734 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs570868985 | chr17:46400803-46400804 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs538641697 | chr17:46400838-46400839 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs539438756 | chr17:46400858-46400859 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs553740644 | chr17:46400874-46400875 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs369659701 | chr17:46400876-46400877 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs188732144 | chr17:46400946-46400947 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs9911663 | chr17:46400970-46400971 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs534857461 | chr17:46401047-46401048 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs193186848 | chr17:46401084-46401085 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs144393927 | chr17:46401116-46401117 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs151173606 | chr17:46401146-46401147 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs542599759 | chr17:46401181-46401182 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs560740475 | chr17:46401218-46401219 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs536485162 | chr17:46401240-46401241 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs7210445 | chr17:46401318-46401319 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs7214589 | chr17:46401400-46401401 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs140166700 | chr17:46401429-46401430 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs373722397 | chr17:46401467-46401468 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs184257756 | chr17:46401538-46401539 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs573349062 | chr17:46401555-46401556 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs542457473 | chr17:46401672-46401673 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs376052013 | chr17:46401684-46401685 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs562146918 | chr17:46401700-46401701 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs187086150 | chr17:46401726-46401727 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs149879132 | chr17:46401787-46401788 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs564447232 | chr17:46401788-46401789 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs144871338 | chr17:46401935-46401936 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs547101753 | chr17:46401979-46401980 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs140790259 | chr17:46402176-46402177 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cancer | 16751803 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 17457667 | CNVD |
Breast cancer | 16951389 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22048815 | CNVD |
Breast cancer | 17603634 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
TAR Syndrome | 17847015 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 19261255 | CNVD |
Lung cancer | 16773561 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Breast cancer | 20031965 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Hereditary breast | 19566914 | CNVD |
Ovarian cancer | 19047089 | CNVD |
Ovarian cancer | 19566914 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
Breast cancer | 16846527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 16397240 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Non-syndromic sensorineural hearing loss | 21084979 | CNVD |
Autism | 22817714 | CNVD |
Breast cancer | 20409316 | CNVD |
Cancer | 17160897 | CNVD |
Frontotemporal lobar degeneration | 19640594 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:46373200-46415000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
2 | chr17:46375800-46415800 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
3 | chr17:46377200-46421000 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
4 | chr17:46386200-46407800 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
5 | chr17:46390200-46429400 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
6 | chr17:46391000-46410400 | Weak transcription | GM12878-XiMat | blood |
7 | chr17:46391000-46420200 | Weak transcription | Primary B cells from peripheral blood | blood |
8 | chr17:46391200-46421200 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
9 | chr17:46391400-46405800 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
10 | chr17:46394000-46400800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
11 | chr17:46394600-46405400 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
12 | chr17:46395200-46402800 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
13 | chr17:46396200-46406200 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
14 | chr17:46396200-46421200 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
15 | chr17:46396800-46414400 | Weak transcription | Primary T cells from cord blood | blood |
16 | chr17:46398600-46407600 | Weak transcription | Primary T cells fromperipheralblood | blood |
17 | chr17:46399800-46405800 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
18 | chr17:46400800-46405600 | Strong transcription | Primary Natural Killer cells fromperipheralblood | blood |